Primary tabs

Perspectives

Accelerated approval of anticancer drugs: a safe choice?

All oncologists know how anxiously cancer patients look forward to the availability in clinical practice of drugs that have yielded positive results in the registration trials.

[more]
Archive

Focus on

Medication review and deprescribing: from theory to implementation in different care settings
Medication review and deprescribingThe increase in life expectancy and the growing availability of effective drugs for the management of chronic diseases are leading to an increase in the number of patients, suffering of multimorbidity, in polypharmacotherapy (regular intake of at least five...
[more]
Archive

Columns

Drugs & Elderly
Safety of drugs in the elderly population in Italy
In recent years, the concept of deprescribing has been introduced, based on the reduction of the number of drugs taken in order to optimize the risk-benefit ratio of polypharmacy taking into account the goals of treatment and the preferences of the patient; however, the available intervention...
[more]
Archive

From regulatory agencies

29 April 2025 CADTH
Données probantes comparatives entre l’estrogénothérapie transdermique et l’estrogénothérapie orale en contexte d’hormonothérapie féminisante
29 April 2025 CADTH
Données probantes comparatives d’hormonothérapies de la ménopause transdermiques et orales
28 April 2025 CADTH
tislélizumab
25 April 2025 CADTH
séladelpar 
24 April 2025 FDA
Heart Pump Accessory Removal: Abbott Removes HeartMate Mobile Power Unit due to Instances of Sudden Power Loss
24 April 2025 FDA
Risk of False Positive Results with Certain Capillary Blood Collection Tubes Used with Magellan Diagnostics LeadCare Testing Systems – FDA Safety Communication
23 April 2025 CADTH
Lymphome à cellules du manteau
22 April 2025 CADTH
efgartigimod alfa
18 April 2025 FDA
Early Alert: Intravascular PICC Catheter Issue from BD
18 April 2025 FDA
Early Alert: Diagnostic Intravascular Catheter Issue from Conavi
Link 
80.211.154.110